LENZ Therapeutics, Inc. (LENZ)
3.495
+0.44
(+14.59%)
USD |
NASDAQ |
Nov 03, 16:00
3.495
0.00 (0.00%)
After-Hours: 16:57
LENZ Therapeutics Cash and Short Term Investments (Quarterly) : 197.30M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 197.30M |
| June 30, 2026 | 220.00M |
| March 31, 2026 | 258.38M |
| December 31, 2025 | 292.35M |
| September 30, 2025 | 202.17M |
| June 30, 2025 | 209.63M |
| March 31, 2025 | 194.09M |
| December 31, 2024 | 209.14M |
| September 30, 2024 | 217.22M |
| June 30, 2024 | 196.23M |
| March 31, 2024 | 213.39M |
| December 31, 2023 | 65.79M |
| Date | Value |
|---|---|
| September 30, 2023 | 233.99M |
| June 30, 2023 | 246.66M |
| March 31, 2023 | 264.10M |
| December 31, 2022 | 268.23M |
| September 30, 2022 | 291.68M |
| June 30, 2022 | 322.29M |
| March 31, 2022 | 339.18M |
| December 31, 2021 | 376.98M |
| September 30, 2021 | 394.95M |
| June 30, 2021 | 382.11M |
| March 31, 2021 | 177.16M |
| December 31, 2020 | 19.82M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Impact BioMedical, Inc. | 0.01M |
| EyePoint, Inc. | 180.47M |
| Ligand Pharmaceuticals, Inc. | 451.51M |
| Enveric Biosciences, Inc. | 8.296M |
| Indivior Pharmaceuticals, Inc. | 305.00M |